Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Title
Intervention Indication Therapeutic Area Year Actions
Tideglusib for congenital myotonic dystrophy Tideglusib (AMO-02; Zentylor; Nypta; NP031112) Myotonic dystrophy Genetic Disorders , Musculoskeletal System , Neurology 2020 View  |  Download
Timolumab for Primary Sclerosing Cholangitis Timolumab (BTT1023) Primary sclerosing cholangitis (PSC) Hepatology 2018 View  |  Download
Timrepigene emparvovec for choroideremia Timrepigene emparvovec (BIIB111; AAV2-REP1; NSR-REP1) Choroideremia Ophthalmology 2020 View  |  Download
Tiragolumab with atezolizumab and pemetrexed and carboplatin or cisplatin for previously untreated advanced non-small-cell lung cancer Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Tiragolumab with atezolizumab for oesophageal squamous cell cancer Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Oesophageal squamous cell carcinoma Head and Neck Cancer 2023 View  |  Download
Tiragolumab with atezolizumab for previously untreated non-small cell lung cancer Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Tiragolumab with atezolizumab for treating stage III non-small cell lung cancer after platinum-based chemoradiotherapy Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Tiratricol for treating monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome) Tiratricol Monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome) Genetic Disorders , Neurology 2022 View  |  Download
Tirzepatide for treating obese or overweight adults Tirzepatide (LY3298176) Obesity Cardiovascular System , Ear Nose and Throat (ENT) 2022 View  |  Download
Tirzepatide for treating type 2 diabetes mellitus Tirzepatide (LY3298176) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications